Trademarks = 4

Forward Citations = 6

Loading Chart...

20 inventors (with patents filed for the assignee):

Alexander Paptchikhine (2 out of 6 patents)

Tom Fleck (2 out of 4 patents)

Magnus Cernerud (2 out of 7 patents)

4. Margit Pelcman (2 out of 5 patents)

5. Alf Nygren (2 out of 5 patents)

6. Helena Lundström (2 out of 6 patents)

7. Claes Löfström (2 out of 5 patents)

8. Emma Andersson (2 out of 5 patents)

9. Gary Johansson (2 out of 14 patents)

10. Rune Ringom (1 out of 9 patents)

11. Erik Ringberg (1 out of 17 patents)

12. Kristin Hammer (1 out of 5 patents)

13. Johan Angbrant (1 out of 2 patents)

14. Bruce Fleck, Legal Representative (1 out of 3 patents)

15. Katarina Beierlein (1 out of 6 patents)

4 patents: Sort by Forward Citations

1. 8410113 - (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof (2013-04-02),

2. 8030316 - Malate salt of (2R)-methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine (2011-10-04),

3. 7812017 - 4-substituted indole and indoline compounds (2010-10-12),

4. 7582767 - Substituted sulphonamide compound and uses thereof (2009-09-01),

Biovitrum Ab is a Swedish biopharmaceutical company specializing in developing innovative therapies for rare diseases. With a strong focus on research and development, Biovitrum is committed to improving the lives of patients with unmet medical needs. The company's portfolio includes treatments for hemophilia, metabolic disorders, and other rare genetic conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#116 in

#153 in Sweden

SE

Biovitrum Ab (publ)